Clal Biotech: Neon Theraputics Raises $106M
Israel's Clal Biotechnology Industries announced that its portfolio company Neon Therapeutics raised $106 million.
December 06, 2017
Clal Biotech: Neon Theraputics Raises $70M
January 8, 2017 | Clal Biotechnology Industries Ltd. announced today that Neon Therapeutics had completed a $70 million financing round. Following the round, Clal Biotechnology will own 5% of US company Neon. The round was led by Partner Fund Management, together with Inbio, Wellington, Fidelity Ventures, and Nextech Invest. Previous investors Third Rock Ventures and […]
January 08, 2017